Endothelial Glycocalyx Shedding Occurs during Ex Vivo Lung Perfusion: A Pilot Study

Background. Damage to the endothelium has been established as a key pathological process in lung transplantation and ex vivo lung perfusion (EVLP), a new technology that provides a platform for the assessment of injured donor lungs. Damage to the lung endothelial glycocalyx, a structure that lines t...

Full description

Bibliographic Details
Main Authors: Timothy M. Sladden, Stephanie Yerkovich, Douglas Wall, Maxine Tan, William Hunt, Jonathan Hill, Ian Smith, Peter Hopkins, Daniel C. Chambers
Format: Article
Language:English
Published: Hindawi Limited 2019-01-01
Series:Journal of Transplantation
Online Access:http://dx.doi.org/10.1155/2019/6748242
id doaj-75abd4ba098346f195c9ba4d11e515e2
record_format Article
spelling doaj-75abd4ba098346f195c9ba4d11e515e22020-11-24T20:44:18ZengHindawi LimitedJournal of Transplantation2090-00072090-00152019-01-01201910.1155/2019/67482426748242Endothelial Glycocalyx Shedding Occurs during Ex Vivo Lung Perfusion: A Pilot StudyTimothy M. Sladden0Stephanie Yerkovich1Douglas Wall2Maxine Tan3William Hunt4Jonathan Hill5Ian Smith6Peter Hopkins7Daniel C. Chambers8Queensland Lung Transplant Service, The Prince Charles Hospital, Brisbane 4032, AustraliaQueensland Lung Transplant Service, The Prince Charles Hospital, Brisbane 4032, AustraliaDepartment of Cardiothoracic Surgery, The Prince Charles Hospital, Brisbane 4032, AustraliaQueensland Lung Transplant Service, The Prince Charles Hospital, Brisbane 4032, AustraliaPerfusion Services, The Prince Charles Hospital, Brisbane 4032, AustraliaSchool of Veterinary Science, The University of Queensland, Gatton 4343, AustraliaDepartment of Anaesthetics, The Prince Charles Hospital, Brisbane 4032, AustraliaQueensland Lung Transplant Service, The Prince Charles Hospital, Brisbane 4032, AustraliaQueensland Lung Transplant Service, The Prince Charles Hospital, Brisbane 4032, AustraliaBackground. Damage to the endothelium has been established as a key pathological process in lung transplantation and ex vivo lung perfusion (EVLP), a new technology that provides a platform for the assessment of injured donor lungs. Damage to the lung endothelial glycocalyx, a structure that lines the endothelium and is integral to vascular barrier function, has been associated with lung dysfunction. We hypothesised that endothelial glycocalyx shedding occurs during EVLP and aimed to establish a porcine model to investigate the mechanism underlying glycocalyx breakdown during EVLP. Methods. Concentrations of endothelial glycocalyx breakdown products, syndecan-1, hyaluronan, heparan sulphate, and CD44, were measured using the ELISA and matrix metalloproteinase (MMP) activity by zymography in the perfusate of both human (n = 9) and porcine (n = 4) lungs undergoing EVLP. Porcine lungs underwent prolonged EVLP (up to 12 hours) with perfusion and ventilation parameters recorded hourly. Results. During human EVLP, endothelial glycocalyx breakdown products in the perfusate increased over time. Increasing MMP-2 activity over time was positively correlated with levels of syndecan-1 (r = 0.886; p=0.03) and hyaluronan (r = 0.943; p=0.02). In the porcine EVLP model, hyaluronan was the only glycocalyx product detectable during EVLP (1 hr: 19 (13–84) vs 12 hr: 143 (109–264) ng/ml; p=0.13). Porcine hyaluronan was associated with MMP-9 activity (r = 0.83; p=0.02) and also with dynamic compliance (r = 0.57; p=0.03). Conclusion. Endothelial glycocalyx products accumulate during both porcine and human EVLP, and this accumulation parallels an accumulation of matrix-degrading enzyme activity. Preliminary evidence in our porcine EVLP model suggests that shedding may be related to organ function, thus warranting additional study.http://dx.doi.org/10.1155/2019/6748242
collection DOAJ
language English
format Article
sources DOAJ
author Timothy M. Sladden
Stephanie Yerkovich
Douglas Wall
Maxine Tan
William Hunt
Jonathan Hill
Ian Smith
Peter Hopkins
Daniel C. Chambers
spellingShingle Timothy M. Sladden
Stephanie Yerkovich
Douglas Wall
Maxine Tan
William Hunt
Jonathan Hill
Ian Smith
Peter Hopkins
Daniel C. Chambers
Endothelial Glycocalyx Shedding Occurs during Ex Vivo Lung Perfusion: A Pilot Study
Journal of Transplantation
author_facet Timothy M. Sladden
Stephanie Yerkovich
Douglas Wall
Maxine Tan
William Hunt
Jonathan Hill
Ian Smith
Peter Hopkins
Daniel C. Chambers
author_sort Timothy M. Sladden
title Endothelial Glycocalyx Shedding Occurs during Ex Vivo Lung Perfusion: A Pilot Study
title_short Endothelial Glycocalyx Shedding Occurs during Ex Vivo Lung Perfusion: A Pilot Study
title_full Endothelial Glycocalyx Shedding Occurs during Ex Vivo Lung Perfusion: A Pilot Study
title_fullStr Endothelial Glycocalyx Shedding Occurs during Ex Vivo Lung Perfusion: A Pilot Study
title_full_unstemmed Endothelial Glycocalyx Shedding Occurs during Ex Vivo Lung Perfusion: A Pilot Study
title_sort endothelial glycocalyx shedding occurs during ex vivo lung perfusion: a pilot study
publisher Hindawi Limited
series Journal of Transplantation
issn 2090-0007
2090-0015
publishDate 2019-01-01
description Background. Damage to the endothelium has been established as a key pathological process in lung transplantation and ex vivo lung perfusion (EVLP), a new technology that provides a platform for the assessment of injured donor lungs. Damage to the lung endothelial glycocalyx, a structure that lines the endothelium and is integral to vascular barrier function, has been associated with lung dysfunction. We hypothesised that endothelial glycocalyx shedding occurs during EVLP and aimed to establish a porcine model to investigate the mechanism underlying glycocalyx breakdown during EVLP. Methods. Concentrations of endothelial glycocalyx breakdown products, syndecan-1, hyaluronan, heparan sulphate, and CD44, were measured using the ELISA and matrix metalloproteinase (MMP) activity by zymography in the perfusate of both human (n = 9) and porcine (n = 4) lungs undergoing EVLP. Porcine lungs underwent prolonged EVLP (up to 12 hours) with perfusion and ventilation parameters recorded hourly. Results. During human EVLP, endothelial glycocalyx breakdown products in the perfusate increased over time. Increasing MMP-2 activity over time was positively correlated with levels of syndecan-1 (r = 0.886; p=0.03) and hyaluronan (r = 0.943; p=0.02). In the porcine EVLP model, hyaluronan was the only glycocalyx product detectable during EVLP (1 hr: 19 (13–84) vs 12 hr: 143 (109–264) ng/ml; p=0.13). Porcine hyaluronan was associated with MMP-9 activity (r = 0.83; p=0.02) and also with dynamic compliance (r = 0.57; p=0.03). Conclusion. Endothelial glycocalyx products accumulate during both porcine and human EVLP, and this accumulation parallels an accumulation of matrix-degrading enzyme activity. Preliminary evidence in our porcine EVLP model suggests that shedding may be related to organ function, thus warranting additional study.
url http://dx.doi.org/10.1155/2019/6748242
work_keys_str_mv AT timothymsladden endothelialglycocalyxsheddingoccursduringexvivolungperfusionapilotstudy
AT stephanieyerkovich endothelialglycocalyxsheddingoccursduringexvivolungperfusionapilotstudy
AT douglaswall endothelialglycocalyxsheddingoccursduringexvivolungperfusionapilotstudy
AT maxinetan endothelialglycocalyxsheddingoccursduringexvivolungperfusionapilotstudy
AT williamhunt endothelialglycocalyxsheddingoccursduringexvivolungperfusionapilotstudy
AT jonathanhill endothelialglycocalyxsheddingoccursduringexvivolungperfusionapilotstudy
AT iansmith endothelialglycocalyxsheddingoccursduringexvivolungperfusionapilotstudy
AT peterhopkins endothelialglycocalyxsheddingoccursduringexvivolungperfusionapilotstudy
AT danielcchambers endothelialglycocalyxsheddingoccursduringexvivolungperfusionapilotstudy
_version_ 1716817725963108352